NDAINHALATIONAEROSOL, METERED
Approved
Jun 2006
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3
Data completeness
4/8 — Partial
Drug data last refreshed 18m ago · AI intelligence enriched 18m ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ADVAIR HFA is a fixed-dose combination inhaler containing fluticasone propionate (inhaled corticosteroid) and salmeterol xinafoate (long-acting beta-2 agonist) for maintenance treatment of asthma and COPD. The dual mechanism provides both anti-inflammatory and bronchodilatory effects. It is delivered via metered-dose inhaler (HFA propellant).
$398MPart D
LOE ApproachingDeclining
LOE-approaching lifecycle signals defensive commercial strategy; team focus shifts to retention, outcome programs, and managed transition.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (3)
Advair HFA in Healthy and HAPE Predisposed Subjects
Started Dec 2023
60 enrolled
Altitude Edema
Advair HFA For Chronic Obstructive Pulmonary Disease(COPD)
Started Mar 2008
247 enrolled
Pulmonary Disease, Chronic Obstructive
A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS
Started Oct 2006
28 enrolled
Asthma
Why This Matters for Your Career
Worked on ADVAIR HFA at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.